Literature DB >> 28536260

Functional role of the three conserved cysteines in the N domain of visual arrestin-1.

Sergey A Vishnivetskiy1, Regina J Lee1, X Edward Zhou2, Andreas Franz1, Qiuyi Xu1, H Eric Xu2, Vsevolod V Gurevich3.   

Abstract

Arrestins specifically bind active and phosphorylated forms of their cognate G protein-coupled receptors, blocking G protein coupling and often redirecting the signaling to alternative pathways. High-affinity receptor binding is accompanied by two major structural changes in arrestin: release of the C-tail and rotation of the two domains relative to each other. The first requires detachment of the arrestin C-tail from the body of the molecule, whereas the second requires disruption of the network of charge-charge interactions at the interdomain interface, termed the polar core. These events can be facilitated by mutations destabilizing the polar core or the anchoring of the C-tail that yield "preactivated" arrestins that bind phosphorylated and unphosphorylated receptors with high affinity. Here we explored the functional role in arrestin activation of the three native cysteines in the N domain, which are conserved in all arrestin subtypes. Using visual arrestin-1 and rhodopsin as a model, we found that substitution of these cysteines with serine, alanine, or valine virtually eliminates the effects of the activating polar core mutations on the binding to unphosphorylated rhodopsin while only slightly reducing the effects of the C-tail mutations. Thus, these three conserved cysteines play a role in the domain rotation but not in the C-tail release.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  activation; arrestin; conformational change; cysteines; photoreceptor; phototransduction; rhodopsin

Mesh:

Substances:

Year:  2017        PMID: 28536260      PMCID: PMC5535024          DOI: 10.1074/jbc.M117.790386

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  The 2.8 A crystal structure of visual arrestin: a model for arrestin's regulation.

Authors:  J A Hirsch; C Schubert; V V Gurevich; P B Sigler
Journal:  Cell       Date:  1999-04-16       Impact factor: 41.582

2.  Scaffolding functions of arrestin-2 revealed by crystal structure and mutagenesis.

Authors:  Shawn K Milano; Helen C Pace; You-Me Kim; Charles Brenner; Jeffrey L Benovic
Journal:  Biochemistry       Date:  2002-03-12       Impact factor: 3.162

Review 3.  The molecular acrobatics of arrestin activation.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Trends Pharmacol Sci       Date:  2004-02       Impact factor: 14.819

4.  The differential engagement of arrestin surface charges by the various functional forms of the receptor.

Authors:  Susan M Hanson; Vsevolod V Gurevich
Journal:  J Biol Chem       Date:  2005-12-08       Impact factor: 5.157

5.  A model for the solution structure of the rod arrestin tetramer.

Authors:  Susan M Hanson; Eric S Dawson; Derek J Francis; Ned Van Eps; Candice S Klug; Wayne L Hubbell; Jens Meiler; Vsevolod V Gurevich
Journal:  Structure       Date:  2008-06       Impact factor: 5.006

6.  The role of arrestin alpha-helix I in receptor binding.

Authors:  Sergey A Vishnivetskiy; Derek Francis; Ned Van Eps; Miyeon Kim; Susan M Hanson; Candice S Klug; Wayne L Hubbell; Vsevolod V Gurevich
Journal:  J Mol Biol       Date:  2009-10-31       Impact factor: 5.469

7.  How does arrestin respond to the phosphorylated state of rhodopsin?

Authors:  S A Vishnivetskiy; C L Paz; C Schubert; J A Hirsch; P B Sigler; V V Gurevich
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

8.  Engineering visual arrestin-1 with special functional characteristics.

Authors:  Sergey A Vishnivetskiy; Qiuyan Chen; Maria C Palazzo; Evan K Brooks; Christian Altenbach; Tina M Iverson; Wayne L Hubbell; Vsevolod V Gurevich
Journal:  J Biol Chem       Date:  2012-12-17       Impact factor: 5.157

9.  Enhanced arrestin facilitates recovery and protects rods lacking rhodopsin phosphorylation.

Authors:  Xiufeng Song; Sergey A Vishnivetskiy; Owen P Gross; Katrina Emelianoff; Ana Mendez; Jeannie Chen; Eugenia V Gurevich; Marie E Burns; Vsevolod V Gurevich
Journal:  Curr Biol       Date:  2009-04-09       Impact factor: 10.834

10.  A Novel Dominant Mutation in SAG, the Arrestin-1 Gene, Is a Common Cause of Retinitis Pigmentosa in Hispanic Families in the Southwestern United States.

Authors:  Lori S Sullivan; Sara J Bowne; Daniel C Koboldt; Elizabeth L Cadena; John R Heckenlively; Kari E Branham; Dianna H Wheaton; Kaylie D Jones; Richard S Ruiz; Mark E Pennesi; Paul Yang; David Davis-Boozer; Hope Northrup; Vsevold V Gurevich; Rui Chen; Mingchu Xu; Yumei Li; David G Birch; Stephen P Daiger
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-05-01       Impact factor: 4.799

View more
  5 in total

Review 1.  Structural biology of G protein-coupled receptor signaling complexes.

Authors:  X Edward Zhou; Karsten Melcher; H Eric Xu
Journal:  Protein Sci       Date:  2018-12-13       Impact factor: 6.725

Review 2.  Arrestin mutations: Some cause diseases, others promise cure.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Prog Mol Biol Transl Sci       Date:  2018-10-24       Impact factor: 3.622

3.  The finger loop as an activation sensor in arrestin.

Authors:  Sergey A Vishnivetskiy; Elizabeth K Huh; Eugenia V Gurevich; Vsevolod V Gurevich
Journal:  J Neurochem       Date:  2020-11-27       Impact factor: 5.372

4.  Lysine in the lariat loop of arrestins does not serve as phosphate sensor.

Authors:  Sergey A Vishnivetskiy; Chen Zheng; Mira B May; Preethi C Karnam; Eugenia V Gurevich; Vsevolod V Gurevich
Journal:  J Neurochem       Date:  2020-07-11       Impact factor: 5.372

5.  Molecular Defects of the Disease-Causing Human Arrestin-1 C147F Mutant.

Authors:  Sergey A Vishnivetskiy; Lori S Sullivan; Sara J Bowne; Stephen P Daiger; Eugenia V Gurevich; Vsevolod V Gurevich
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-01-01       Impact factor: 4.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.